Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Challenges in the management of epilepsy in resource-poor countries

Abstract

Of the 50 million people with epilepsy worldwide, around 80% reside in resource-poor countries, which are ill-equipped to tackle the enormous medical, social and economic challenges posed by epilepsy. The capability to identify people with epilepsy and provide cost-effective care is compromised by widespread poverty, illiteracy, inefficient and unevenly distributed health-care systems, and social stigma and misconceptions surrounding the disease. Several studies have reported that a large proportion of patients with epilepsy in resource-poor countries never receive appropriate treatment for their condition, and many, although diagnosed and initiated on treatment, soon discontinue treatment. The high cost of treatment, a lack of availability of antiepileptic drugs, and superstitious and cultural beliefs contribute to a large epilepsy treatment gap. A substantial proportion of the current burden of epilepsy in resource-poor countries could be minimized by educating the public about positive features of life with epilepsy, informing primary and secondary physicians about current trends in the management of epilepsies, scaling up routine availability of low-cost antiepileptic drugs, and developing cost-effective epilepsy surgery programs. A comprehensive epilepsy care model should consider the marked heterogeneity of the disorder and its variable effects on the patient, family and community.

Key Points

  • Resource-poor countries carry an enormous burden of epilepsy

  • A substantial proportion of patients in resource-poor countries never receive appropriate treatment

  • This treatment gap can be minimized by educating primary care physicians on how to diagnose epilepsy and administer phenobarbital treatment

  • Few of the epilepsy surgery programs in resource-poor countries have produced results comparable to those in wealthier countries

  • Epilepsy care programs in resource-poor countries must adjust to local sociocultural, political and economic scenarios

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The epilepsy care pyramid.

Similar content being viewed by others

References

  1. Kale, R. Global campaign against epilepsy: the treatment gap. Epilepsia 43 (Suppl. 6), 31–33 (2002).

    Article  PubMed  Google Scholar 

  2. World Health Organization. Epilepsy in the WHO Africa Region, Bridging the Gap: the Global Campaign Against Epilepsy “Out of the Shadows.” (WHO Press, Geneva, 2004).

  3. World Health Organization. Atlas. Epilepsy Care in the World 2005. (WHO Press, Geneva, 2005).

  4. The World Bank. World Bank list of economies (July 2008). http://siteresources.worldbank.org/DATASTATISTICS/Resources/CLASS.XLS

  5. Begley, C. E. et al. Cross-country measures for monitoring epilepsy care. Epilepsia 48, 990–1001 (2007).

    Article  PubMed  Google Scholar 

  6. Forsgren, I., Beghi, E., Oun, A. & Sillanpaa, M. The epidemiology of epilepsy in Europe—a systematic review. Eur. J. Neurol. 12, 245–253 (2005).

    Article  CAS  PubMed  Google Scholar 

  7. Theodore, W. H. et al. Epilepsy in North America: a report prepared under the auspices of the Global Campaign against Epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization. Epilepsia 47, 1700–1722 (2006).

    Article  PubMed  Google Scholar 

  8. Mac, T. L. et al. Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol. 6, 533–543 (2007).

    Article  PubMed  Google Scholar 

  9. Burneo, J. G., Tellez-Zenteno, J. & Wiebe, S. Understanding the burden of epilepsy in Latin America: a systematic review of its prevalence and incidence. Epilepsy Res. 66, 63–74 (2005).

    Article  PubMed  Google Scholar 

  10. Preux, P.-M. & Druet-Cabanac, M. Epidemiology and etiology of epilepsy in sub-Saharan Africa. Lancet Neurol. 4, 21–31 (2005).

    Article  PubMed  Google Scholar 

  11. de Bittencourt, P. R. M. et al. Epilepsy in the tropics: 1. Epidemiology, socioeconomic risk factors and etiology. Epilepsia 37, 1121–1127 (1996).

    Article  CAS  PubMed  Google Scholar 

  12. Jallon, P. Epilepsy and epileptic disorders, an epidemiological marker? Contribution of descriptive epidemiology. Epileptic Disord. 4, 1–13 (2002).

    PubMed  Google Scholar 

  13. Sridharan, R. & Murthy, B. N. Prevalence and pattern of epilepsy in India. Epilepsia 40, 631–636 (1999).

    Article  CAS  PubMed  Google Scholar 

  14. Radhakrishnan, K. et al. Prevalence, knowledge, attitude, and practice of epilepsy in Kerala, South India. Epilepsia 41, 1027–1035 (2000).

    Article  CAS  PubMed  Google Scholar 

  15. Wang, W. Z. et al. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 60, 1544–1545 (2003).

    Article  CAS  PubMed  Google Scholar 

  16. Aarli, J. A. Neurology and WHO: challenges and issues. A report. World Neurol. 17, 10–11 (2002).

    Google Scholar 

  17. Singhal, B. S. Neurology in developing countries: a population perspective. Arch. Neurol. 55, 1019–1021 (1998).

    Article  CAS  PubMed  Google Scholar 

  18. Dua, T., de Boer, H. M., Prilipko, L. L. & Saxena, S. Epilepsy care in the world: results of an ILAE/IBE/WHO global campaign against epilepsy survey. Epilepsia 47, 1225–1231 (2006).

    Article  PubMed  Google Scholar 

  19. Mani, K. S. Global campaign against epilepsy. Agenda for IEA/IES. Neurol. India 46, 1–4 (1998).

    Google Scholar 

  20. Binnie, C. D. & Stefan, H. Modern electroencephalogahy: its role in epilepsy management. Clin. Neurophysiol. 110, 1671–1697 (1999).

    Article  CAS  PubMed  Google Scholar 

  21. Wang, W. Z. et al. Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol. 5, 46–52 (2006).

    Article  PubMed  Google Scholar 

  22. Mani, K. S., Rangan, G., Srinivas, H. V., Srindharan, V. S. & Subbakrishna, D. K. Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study. Lancet 357, 1316–1320 (2001).

    Article  CAS  PubMed  Google Scholar 

  23. Commission on Neuroimaging of the International League Against Epilepsy. Guidelines for neuroimaging evaluation of patients with uncontrolled epilepsy considered for surgery. Epilepsia 39, 1375–1376 (1998).

  24. Sylaja, P. N., Radhakrishnan, K., Kesavadas, C. & Sarma, P. S. Seizure outcome after anterior temporal lobectomy and its predictors in patients with apparent temporal lobe epilepsy and normal MRI. Epilepsia 45, 803–808 (2004).

    Article  CAS  PubMed  Google Scholar 

  25. Meinardi, H., Scott, R. A., Reis, R. & Sander, J. W. The treatment gap in epilepsy: the current situation and ways forward. Epilepsia 42, 136–149 (2001).

    Article  CAS  PubMed  Google Scholar 

  26. Mbuba, C. K., Ngugi, A. K., Newton, C. R. & Carter, J. A. The epilepsy treatment gap in developing countries: a systematic review of the mahnitude, causes, and intervention strategies. Epilepsia 49, 1491–1503 (2008).

    Article  PubMed  PubMed Central  Google Scholar 

  27. Das, K. et al. Evaluation of socio-economic factors causing discontinuation of epilepsy treatment resulting in seizure recurrence: a study in an urban epilepsy clinic in India. Seizure 16, 601–607 (2007).

    Article  CAS  PubMed  Google Scholar 

  28. Chisholm, D. on behalf of WHO-CHOICE. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis. Epilepsia 46, 751–759 (2005).

    Article  PubMed  Google Scholar 

  29. World Health Organization. Tables of costs and prices used in WHO-CHOICE analysis. http://www.who.int/choice/costs/en/ (2005).

  30. Radhakrishnan, K., Nayak, S. D., Kumar, S. P. & Sarma, P. S. Profile of antiepileptic pharmacotherapy in a tertiary referral center in South India: a pharmacoepidemiological and pharmacoeconomic study. Epilepsia 40, 179–185 (1999).

    Article  CAS  PubMed  Google Scholar 

  31. Kwan, P. & Brodie, M. J. Early identification of refractory epilepsy. N. Engl. J. Med. 342, 314–319 (2000).

    Article  CAS  PubMed  Google Scholar 

  32. Engel, J. Jr. Etiology as a risk factor for medically refractory epilepsy. A case for early surgical intervention. Neurology 51, 1243–1244 (1998).

    Article  PubMed  Google Scholar 

  33. Radhakrishnan, K., Fried, I. & Cascino, G. D. Lesionectomy: management of substrate-directed epilepsies. In Epilepsy. A Comprehensive Textbook (eds Engel, J. J. & Pedley, T. A.), 1891–1905 (Lippincott Williams & Wilkins, Philadephia, 2008).

    Google Scholar 

  34. Wieser, H.-G. & Silfvenius, H. Overview: epilepsy surgery in developing countries. Epilepsia 41 (Suppl. 4), S3–S9 (2000).

    Article  PubMed  Google Scholar 

  35. Sylaja, P. N. & Radhakrishnan, K. Surgical management of epilepsy. Problems and pitfalls in developing countries. Epilepsia 44 (Suppl. 1), 48–50 (2003).

    Article  PubMed  Google Scholar 

  36. Asadi-Pooya, A. A. & Sperling, M. R. Strategies for surgical treatment of epilepsies in developing countries. Epilepsia 49, 381–385 (2008).

    Article  PubMed  Google Scholar 

  37. Rathore, C. et al. Outcome after corpus callosotomy in children with injurious drop attacks and severe mental retardation. Brain Dev. 29, 577–585 (2007).

    Article  PubMed  Google Scholar 

  38. Chandra, P. S. et al. Hemispherotomy for intractable epilepsy. Neurol. India 56, 127–132 (2008).

    Article  PubMed  Google Scholar 

  39. Radhakrishnan, K. Epilepsy surgery in India. Neurol. India 57, 4–6 (2009).

    Article  PubMed  Google Scholar 

  40. Griggs, J. J. & Engel, J. Jr. Epilepsy surgery and racial divide. Neurology 64, 8–9 (2005).

    Article  PubMed  Google Scholar 

  41. Engel, J. Jr. Surgical treatment for epilepsy: too little, too late. JAMA 300, 2548–2550 (2008).

    Article  CAS  PubMed  Google Scholar 

  42. McLin, W. M. & de Boer, H. M. Public perceptions about epilepsy. Epilepsia 36, 957–959 (1995).

    Article  CAS  PubMed  Google Scholar 

  43. Caveness, W. F. & Gallup, G. H. Jr. A survey of public attitudes toward epilepsy in 1979 with an indication of trends over the past thirty years. Epilepsia 21, 509–518 (1980).

    Article  CAS  PubMed  Google Scholar 

  44. Hills, M. D. & MacKenzie, H. C. New Zealand community attitudes toward people with epilepsy. Epilepsia 43, 1583–1589 (2002).

    Article  PubMed  Google Scholar 

  45. Jacoby, A., Gorry, J., Gamble, C. & Baker, G. A. Public knowledge, private grief: a study of public attitudes of epilepsy in the United Kingdom and implications for stigma. Epilepsia 45, 1405–1415 (2004).

    Article  PubMed  Google Scholar 

  46. Fong, C. G. & Hung, A. Public awareness, attitude and understanding of epilepsy in Hong Kong special administrative region, China. Epilepsia 43, 311–316 (2002).

    Article  PubMed  Google Scholar 

  47. Pandian, J. D., Santosh, D., Kumar, T. S., Sarma, P. S. & Radhakrishnan, K. High school students' knowledge, attitude, and practice with respect to epilepsy in Kerala, southern India. Epilepsy Behav. 9, 492–497 (2006).

    Article  PubMed  Google Scholar 

  48. Huang, W. J. An Asian perspective on relationship and marriage education. Fam. Process 44, 161–173 (2005).

    Article  PubMed  Google Scholar 

  49. Kleinmann, A. et al. The social course of epilepsy: chronic experience as social experience in interior China. Social Sci. Med. 40, 1319–1330 (1995).

    Article  Google Scholar 

  50. Agarwal, P. et al. Epilepsy in India: nuptiality behaviour and fertility. Seizure 15, 409–415 (2006).

    Article  CAS  PubMed  Google Scholar 

  51. Santosh, D., Kumar, T. S., Sarma, P. S. & Radhakrishnan, K. Women with onset of epilepsy prior to marriage: disclose or conceal? Epilepsia 48, 1007–1010 (2007).

    Article  PubMed  Google Scholar 

  52. Watts, A. E. Treating epilepsy in Malawi: lessons learned. Trop. Doctor 20, 52–55 (1990).

    Article  CAS  Google Scholar 

  53. Feksi, A. T., Kaamungisha, J., Sander, J. W., Gatiti, S. & Shorvon, S. D. Comprehensive primary health care: antiepileptic drug programme in rural and semi-urban Kenya: ICBERG (International Community-based Epilepsy Research Group). Lancet 337, 406–409 (1991).

    Article  CAS  PubMed  Google Scholar 

  54. Gourie-Devi, M., Satishchandra, P. & Gururaj, G. Epilepsy control program in India: a district model. Epilepsia 44 (Suppl. 1), 58–62 (2003).

    Article  PubMed  Google Scholar 

  55. de Boer, H. M. “Out of the shadows”: a global campaign against epilepsy. Epilepsia 43 (Suppl. 6), 7–8 (2002).

    Article  PubMed  Google Scholar 

  56. Sander, J. W. Global Campaign Against Epilepsy. Overview of the demonstration projects. Epilepsia 43 (Suppl. 6), 34–36 (2002).

    Article  PubMed  Google Scholar 

  57. ndian Epilepsy Society. Indian Guidelines for the Management of Epilepsy: GEMIND. http://www.epilepsyindia.org/gemind-main.asp (2008).

Download references

Acknowledgements

I wish to thank my colleagues at the R. Madhavan Nayar Center for Comprehensive Epilepsy Care, Trivandrum, Kerala, India for their help in compiling this review.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Radhakrishnan, K. Challenges in the management of epilepsy in resource-poor countries. Nat Rev Neurol 5, 323–330 (2009). https://doi.org/10.1038/nrneurol.2009.53

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneurol.2009.53

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing